A growing field of study is beginning to connect the dots between social determinants of health and changes in tumor biology.

What health experts make of Project 2025, and what they say Trump’s personal proposals on health care could mean for ...

Without patents, companies might not recoup their investment, leading to fewer new treatments for patients in need. But by ...

As for-profit Tenet Healthcare slims its hospital portfolio, it found an unlikely buyer for its Alabama hospitals: Florida’s ...

Shifting from topic to topic, with few connections, is one of several disjointed and occasionally incoherent verbal habits ...

LONDON — Patients in England with a rare blood disorder will now be able to receive the world’s first CRISPR-based medicine, ...

This is the second in a periodic series from STAT about how UnitedHealth Group wields its unrivaled physician empire to boost ...

An underwhelming earnings report and ongoing questions about increasing competition in the booming obesity medicine field ...

The director general of the World Health Organization announced Wednesday that he will convene a panel of experts to advise him on whether the expanding outbreak of mpox in sub-Saharan Africa ...

CVS Health continued to pay out more than it expected for the medical claims of its Medicare Advantage enrollees in the second quarter, forcing the company to lower its estimates for this year’s ...

The U.S. Food and Drug Administration has scolded Bristol Myers Squibb for making false and misleading claims about a lung cancer treatment on a website aimed at physicians. In an Aug. 1 letter, the ...

Novo Nordisk is pulling its regulatory filings to expand the use of Wegovy for a common type of heart failure, saying that is waiting for more data.